|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Profit before tax | ||||
| Adjustments: | ||||
| depreciation and impairment of property, plant and equipment | ||||
| amortization of intangible assets and right of use assets | ||||
| allowance for doubtful accounts | ||||
| net interest expense | ||||
| (gain) from the disposal of non-current assets | ||||
| Change in other provisions | ||||
| Change in employee benefits | ||||
| Other non-cash expenses, net | ||||
| Working capital changes net of the effects from purchase of controlled entity: | ||||
| - inventories and contract assets | ||||
| - trade receivables and other assets | ||||
| - trade payables, contract liabilities, advances and other liabilities | ||||
| Interest paid | ||||
| Interest received | ||||
| Income tax paid | ||||
| Net Cash Flows from operating activities | ||||
| Cash Flow from investing activities | ||||
| Purchase of property, plant and equipment | ||||
| Proceeds from sale of property plant and equipment | ||||
| Purchase of intangible assets | ||||
| Proceeds from/ (purchase of) investments in financial assets | ||||
| Proceeds from life insurance policies redemption | ||||
| Business combination - net of cash acquired | ||||
| Net Cash Flows used in investing activities | ||||
| Cash Flow from financing activities | ||||
| Net proceeds from follow on offering of ordinary shares | ||||
| Acquisition of non-controlling interests | ||||
| Dividends paid | ||||
| Payment of principal portion of lease liabilities | ||||
| Proceeds from borrowings | ||||
| Repayments of borrowings | ||||
| Net Cash Flows from/(used in) financing activities | ||||
| Net change in cash and cash equivalents | ||||
| Net foreign exchange differences on cash and cash equivalents | ||||
| Cash and cash equivalents at Beginning Balance | ||||
| Cash and cash equivalents at Ending Balance | ||||
Loading...
